Online citations, reference lists, and bibliographies.
← Back to Search

Hydrocortisone And Airflow Impairment In Aspirin-induced Asthma.

A. Szczeklik, E. Nizankowska, G. Czerniawska-Mysik, S. Šek
Published 1985 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
We studied the effects of intravenous injection of hydrocortisone, as compared to its solvent, in 31 patients with aspirin-induced asthma. Mean FEV1 fell significantly 5 minutes after an intravenous bolus of 300 mg of hydrocortisone, but not after the solvent, and returned to the initial values 1 hour later. Only three of 31 patients displayed at this time clinical signs of increased impairment of airflow that resolved spontaneously. Neither in these three patients nor in another patient known already to respond with bronchoconstriction to 30 to 50 mg of hydrocortisone did intravenous injections of 20 mg of methylprednisolone, 4 mg of dexamethasone, or 4 mg of betamethasone produce any signs of bronchial obstruction. In the whole group of patients, mean FEV1 increased significantly 3 to 5 hours after hydrocortisone injection. It is hypothesized that hydrocortisone might induce early bronchoconstriction in patients with aspirin-induced asthma through its inhibitory effects on prostanoid biosynthesis. Use of intravenous steroids other than hydrocortisone is advisable in patients with aspirin-induced asthma.
This paper references
10.1016/S0140-6736(60)92178-4
A SEVERE ANAPHYLACTOID REACTION TO HYDROCORTISONE
R. A. King (1960)
10.1136/BMJ.1.5278.615
Anaphylactic Reactions to Hydrocortisone Injections
J. A. O'Garra (1962)
10.1042/CS043015PA
Time course of response to corticosteroids in chronic bronchial asthma.
R. Ellul-Micallef (1972)
10.1016/0091-6749(74)90049-9
Anaphylaxis-like reactions to corticosteroid therapy.
L. Mendelson (1974)
10.1136/bmj.1.5949.67
Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.
A. Szczeklik (1975)
10.1016/S0090-6980(75)80087-6
Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig.
R. Gryglewski (1975)
10.1136/thx.30.3.312
Intravenous prednisolone in chronic bronchial asthma.
R. Ellul-Micallef (1975)
Untoward reactions to corticosteroids: intolerance to hydrocortisone.
N. Kounis (1976)
10.1016/0091-6749(77)90106-3
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis.
A. Szczeklik (1977)
10.7326/0003-4819-111-5-448_5
Allergy, principles and practice
E. Middleton (1978)
10.1136/bmj.1.6126.1521
Adverse bronchial reactions to intravenous hydrocortisone in two aspirin-sensitive asthmatic patients.
M. Partridge (1978)
10.1016/S0140-6736(79)92407-3
STEROIDS IN ASTHMA
J. Toogood (1979)
Clinical evaluation of five spirometers. Monaghan M403, Pneumoscreen, Spirotron, Vicatest and Vitalograph.
A. M. Wever (1981)
10.1016/0165-6147(81)90307-2
Glucocorticoids, phospholipase A2 and inflammation
R. Flower (1981)
10.1016/0091-6749(81)90184-6
Bronchospasm caused by intravenous hydrocortisone sodium succinate (Solu-Cortef) in aspirin-sensitive asthmatics.
B. Dajani (1981)
10.1016/0002-9343(83)90537-5
Aspirin and allergic diseases: a review.
G. Settipane (1983)
10.1016/0091-6749(83)90054-4
The immediate effects of cortisol on pulmonary function in normals and asthmatics.
J. Ramsdell (1983)
10.1016/0091-6749(84)90351-8
Aspirin idiosyncracy and tolerance.
P. Vanarsdel (1984)
10.1016/0091-6749(84)90361-0
Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin.
D. Stevenson (1984)
10.1016/0006-2952(84)90362-9
Interactions between prostaglandins and leukotrienes.
F. A. Kuehl (1984)
10.1016/0091-6749(84)90401-9
Hypotheses on the contribution of late-phase allergic responses to the understanding and treatment of allergic diseases
M. Kaliner (1984)
10.1016/0090-6980(84)90232-6
Anti-phospholipase proteins.
M. Di Rosa (1984)



This paper is referenced by
10.1016/j.alit.2020.08.001
Japanese guidelines for adult asthma 2020.
Yoichi Nakamura (2020)
10.1016/j.alit.2016.12.005
Japanese guidelines for adult asthma 2017.
M. Ichinose (2017)
10.1016/B978-0-12-803507-8.00003-1
Chapter 3 – Special Considerations
Stephen P. Kasper (2016)
10.2332/allergolint.14-RAI-0766
Japanese Guideline for Adult Asthma 2014.
K. Ohta (2014)
10.2165/00063030-200013010-00004
Aspirin-Sensitive Asthma
hae-sim park (2012)
10.2165/00003495-198600324-00011
Analgesics, Allergy and Asthma
A. Szczeklik (2012)
10.1007/BF03258504
Drug-Induced Asthma
J. S. Klein (2012)
10.1016/j.jaci.2011.05.026
Hypersensitivity to systemic corticosteroids in aspirin-sensitive patients with asthma.
A. Szczeklik (2011)
10.2332/allergolint.11-RAI-0327
Japanese guideline for adult asthma.
K. Ohta (2011)
10.4168/aair.2011.3.4.277
Acute Urticaria Induced by Oral Methylprednisolone
E. J. Jang (2011)
10.1016/J.RMR.2011.02.015
Facteurs déclenchants : médicaments
C. Sanfiorenzo (2011)
10.29252/JMJ.7.4.8
A Case Report Of Aspirin-Iinduced Asthma (AIA) Syndrome After Ingestion Of Naproxen
Saeed Hamidizadeh (2009)
10.1016/B978-0-323-05659-5.00069-3
Hypersensitivity to Aspirin and Non-Steroidal Antiinflammatory Drugs
A. Szczeklik (2009)
10.1183/09031936.00138707
Global strategy for asthma management and prevention: GINA executive summary
E. Bateman (2008)
10.1007/978-0-387-68792-6_22
Drug and Radiation Toxicity
A. Gal (2008)
Differenzialdiagnose der rezidivierenden Polyposis nasi: Das Analgetika-Asthma-Syndrom
W. Randerath (2007)
GINA EXECUTIVE COMMITTEE
P. O'Byrne (2006)
10.2165/00151829-200504050-00004
Pathogenesis and Management of Aspirin-Intolerant Asthma
Y. Obase (2005)
GINA Workshop Report (Updated 2004) Global Strategy for Asthma Management and Prevention
E. Bateman (2005)
10.1007/S11882-005-0050-8
Immunoglobulin e-mediated reactions to corticosteroids
H. Cheam (2005)
10.1016/S0301-0546(03)79277-5
Particularidades de la intolerancia AINEs en niños
J. Arceo (2003)
10.1016/S1081-1206(10)62151-5
An anaphylactic reaction to intra-articular triamcinolone: a case report and review of the literature.
J. Karsh (2003)
10.1385/CRIAI:24:2:149
Crossreacting drugs and chemicals
K. Woessner (2003)
10.1007/s00101-002-0284-y
Anaphylaktischer Schock nach intravenöser Hydrokortisonsuccinatgabe
W. Hölz (2002)
10.1016/B978-012079028-9/50117-4
Chapter 42 – Drugs
G. Gibson (2002)
10.1007/S11882-002-0006-1
The mechanisms of aspirin-intolerant asthma and its management
M. McGeehan (2002)
10.1517/14656566.4.1.13
Paracetamol and asthma
G. Karakaya (2001)
10.1042/CS1000019
Hydrocortisone abolishes the angiotensin II-mediated potentiation of endothelin-1 in bovine bronchi.
A. Brown (2001)
10.1201/B14023-17
Aspirin, Nonsteroidal Anti-Inflammatory Drugs and Preservatives as Causes for Severe Asthma
D. Stevenson (2001)
10.1378/CHEST.118.5.1470
Aspirin and asthma.
K. Babu (2000)
Réactions anaphylactiques aux corticostéroïdes systémiques
P. Beynel (2000)
10.1016/S0091-6749(99)70106-5
Aspirin-induced asthma: advances in pathogenesis and management.
A. Szczeklik (1999)
See more
Semantic Scholar Logo Some data provided by SemanticScholar